NAVY
Lockheed Martin Integrated Systems, Incorporated, Bethesda, Maryland, is being
awarded a $31,225,393 cost-plus-award-fee contract for design agent services
for the
AN/SQQ-89(V) Surface Ship Undersea Warfare Combat System. Work will be
performed
in Syracuse, New York (53%); Cherry Hill, New Jersey (37%); Bethesda, Maryland
(1%);
Eagan, Minnesota (7%); and Binghamton, New York (2%), and is expected to be
completed
by September 2000. Contract funds will not expire at the end of the current
fiscal year. This contract was competitively procured with two proposals
solicited and two offers received.
The Naval Sea Systems Command, Arlington, Virginia, is the contracting activity
(N00024-96-C-6301).
Lockheed Martin Integrated Systems, Incorporated, Bethesda, Maryland, is being
awarded a $65,000,803 firm-fixed-price contract for production of AN/SQQ-89(V)
Surface
Ship Undersea Warfare Combat Systems. Work will be performed in Bethesda,
Maryland
(5%); Syracuse, New York (40%); Americus, Georgia (40%); Ocala, Florida (10%);
Binghamton, New York (3%); and Eagan, Minnesota (2%), and is expected to be
completed by May 2003. Contract funds will not expire at the end of the
current fiscal year. This contract was competitively procured with two
proposals solicited and two offers received. The Naval Sea Systems Command,
Arlington, Virginia, is the contracting activity (N00024-96-C-6300).
Lockheed Engineering and Sciences Company, San Diego, California, is being
awarded a $7,776,542 modification to previously awarded contract
N00024-93-C-6100 for systems support for the Deep Submergence Systems Program.
Work will be performed in San Diego, California, and is expected to be
completed by September 1998. Contract funds in the amount of $3,818,000 will
expire at the end of the current fiscal year. This contract was not
competitively procured. The Naval Sea Systems Command, Arlington, Virginia, is
the contracting activity.
Page 2 - Contracts con't 2/27/96
DEFENSE LOGISTICS AGENCY
Bergen Brunswig Drug Co., Orange, California, is being awarded a
$57,500,000 firm fixed price contract for pharmaceuticals under the Prime
Vendor Pharmaceutical program. Approximately six proposals were solicited and
two were received. Work will be performed in Dallas, Texas; Houston, Texas;
San Antonio, Texas; and Tulsa, Oklahoma, and is expected to be completed by
February 1997. Funds will not expire at the end of the fiscal year. The Defense
Personnel Support Center, Philadelphia, Pennsylvania, is the contracting
activity (SP0200-94-D-7003).
